Trial NCT04516746
Publication Sobieszczyk M, J Clin Invest, 2022
Dates: 2020-08-28 to 2021-01-15
Funding: Mixed (AstraZeneca; the Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority; the Infectious Diseases Clinical Research Consortium through the National Institute of Allergy and Infectious Diseases, part of the NIH)
Conflict of interest: Yes